Product NDC: | 24208-353 |
Proprietary Name: | ALREX |
Non Proprietary Name: | loteprednol etabonate |
Active Ingredient(s): | 2 mg/mL & nbsp; loteprednol etabonate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SUSPENSION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-353 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020803 |
Marketing Category: | NDA |
Start Marketing Date: | 19980309 |
Package NDC: | 24208-353-10 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (24208-353-10) > 10 mL in 1 BOTTLE, DROPPER |
NDC Code | 24208-353-10 |
Proprietary Name | ALREX |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (24208-353-10) > 10 mL in 1 BOTTLE, DROPPER |
Product NDC | 24208-353 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loteprednol etabonate |
Dosage Form Name | SUSPENSION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 19980309 |
Marketing Category Name | NDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | LOTEPREDNOL ETABONATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |